Zydus Lifesciences dividend and valuation
Valuation
Zydus Lifesciences paid ₹1.00 per share in dividends over the last 12 months (yield 0.1%). Last ex-dividend date: July 24, 2026. The P/E ratio is 28.7. The average price target of 29 analysts is ₹1,238.46.
Data as of November 22, 2026
Zydus Lifesciences compared with similar companies
Zydus Lifesciences's P/E (trailing 12 months): 28.7, in line with the median of a group of 11 similar companies (28.7).
| Metric | Zydus Lifesciences | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 28.7 | 28.7 | 17.9 – 56.8 | Middle |
| Forward P/E | 24.3 | 24.3 | 17.9 – 29.1 | Middle |
| EV/EBITDA | 18.3 | 18.3 | 13.8 – 28.7 | Middle |
| Price/book | 4.30 | 3.24 | 1.91 – 7.00 | Middle |
| Price/sales | 3.94 | 4.10 | 2.84 – 11.0 | Middle |
| Gross margin | 72.2% | 74.7% | 61.5% – 79.2% | Middle |
| Operating margin | 17.2% | 22.2% | 15.1% – 32.7% | Middle |
| Net margin | 13.8% | 16.2% | 12.2% – 33.1% | Middle |
| ROE | 14.7% | 15.2% | 11.4% – 20.3% | Middle |
| Debt/equity | 0.46 | 0.21 | 0.03 – 0.41 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Zydus Lifesciences: valuation over time
On the latest fiscal year's earnings (2026), Zydus Lifesciences's P/E today is 24.0, in line with the median of its last 10 fiscal years (21.0; between 15.9 and 30.4 from 2017 to 2026). Relative to earnings, it costs about the same as in the past. The dividend yield (0.1%) is below the median of the last 10 fiscal years (0.9%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| Mar 2026 | ₹871.20 | ₹50.09 | 17.4 | ₹1.00 | 0.1% |
| Mar 2025 | ₹886.40 | ₹44.97 | 19.7 | ₹11.00 | 1.2% |
| Mar 2024 | ₹1,007.35 | ₹37.91 | 26.6 | ₹3.00 | 0.3% |
| Mar 2023 | ₹491.55 | ₹19.35 | 25.4 | ₹6.00 | 1.2% |
| Mar 2022 | ₹348.50 | ₹21.90 | 15.9 | ₹2.50 | 0.7% |
| Mar 2021 | ₹440.90 | ₹21.51 | 20.5 | ₹3.50 | 0.8% |
| Mar 2020 | ₹267.25 | ₹11.49 | 23.3 | ₹3.50 | 1.3% |
| Mar 2019 | ₹335.95 | ₹18.06 | 18.6 | ₹3.50 | 1.0% |
| Mar 2018 | ₹377.85 | ₹17.53 | 21.6 | ₹3.50 | 0.9% |
| Mar 2017 | ₹442.00 | ₹14.56 | 30.4 | ₹3.20 | 0.7% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- ₹1.2T
- Enterprise value
- ₹1.31T
- EV/revenue
- 4.31
Profitability and growth
- ROA
- 6.4%
- ROIC
- 8.0%
- Revenue growth (year over year)
- 29.2%
- Earnings growth (year over year)
- -25.8%
Financial health
- Total cash
- ₹52.16B
- Total debt
- ₹139.66B
- Current ratio
- 1.02
- Quick ratio
- 0.53
Dividends
- Annual dividend per share
- ₹1.00
- Dividend yield
- 0.1%
- Payout ratio
- 2.4%
- Ex-dividend date
- July 24, 2026
Analysts and estimates
- Average price target
- ₹1,238.46
- Median price target
- ₹1,254.00
- High price target
- ₹1,457.48
- Low price target
- ₹800.00
- Analysts with a price target
- 29
- Consensus
- Hold
- Forward EPS
- ₹49.38
- EPS estimate, current year
- ₹39.85
Shares and trading
- Beta
- 0.31
- Average volume
- 1.5M
- Shares outstanding
- 997.5M
- Float
- 241.09M
- Institutional ownership
- 16.2%
- Insider ownership
- 75.2%
